BioCentury
ARTICLE | Clinical News

Modrenal trilostane: Phase II started

September 27, 2004 7:00 AM UTC

BIVN began an open-label, U.S. Phase II study in up to 43 patients who have androgen independent disease and rising prostate specific antigen (PSA) levels. ...